Impact of Donor and Recipient Sex and Parity on Outcomes of HLA-Identical Sibling Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 7, 2006, Pages 758-769

  Loren, Alison W ^a,b   Bunin, Greta R ^b,c   Boudreau, Christian ^d,f   Champlin, Richard E ^e   Cnaan, Avital ^b,c   Horowitz, Mary M ^d   Loberiza, Fausto R ^d,g   Porter, David L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f UNIVERSITY OF WATERLOO   (Canada)

^g UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Allogeneic stem cell transplantation; Graft versus host disease; Pregnancy

Indexed keywords

CYCLOSPORIN A; METHOTREXATE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER MORTALITY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DONOR SELECTION; FEMALE; HEMATOLOGIC MALIGNANCY; HLA TYPING; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MONOZYGOTIC TWINS; NULLIPARA; PARITY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SIBLING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CHRONIC DISEASE; DIRECTED TISSUE DONATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; MIDDLE AGED; PARITY; PREGNANCY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33745166296     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.03.015     Document Type: Article

References (61)

1. Gale R.P., Bortin M.M., van Bekkum D.W., et al. Risk factors for acute graft-versus-host disease. Br J Haematol 67 (1987) 397-406
2. Flowers M.E., Pepe M.S., Longton G., et al. Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation. Br J Haematol 74 (1990) 492-496
3. Atkinson K., Farrell C., Chapman G., Downs K., Penny R., and Biggs J. Female marrow donors increase the risk of acute graft-versus-host disease. effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum. Br J Haematol 63 (1986) 231-239
4. Weisdorf D., Hakke R., Blazar B., et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 51 (1991) 1197-1203
5. Nash R.A., Pepe M.S., Storb R., et al. Acute graft-versus-host disease. analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 80 (1992) 1838-1845
6. Carlens S., Ringden O., Remberger M., et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation. a retrospective single centre analysis. Bone Marrow Transplant 22 (1998) 755-761
7. Remberger M., Kumlien G., Aschan J., et al. Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 8 (2002) 674-682
8. Przepiorka D., Smith T.L., Folloder J., et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 94 (1999) 1465-1470
9. Bross D.S., Tutschka P.J., Farmer E.R., et al. Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow. Blood 63 (1984) 1265-1270
10. Randolph S.S.B., Gooley T.A., Warren E.H., Appelbaum F.R., and Riddell S.R. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 103 (2004) 347-352
11. Kollman C., Howe C.W., Anasetti C., et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors. the effect of donor age. Blood 98 (2001) 2043-2051
12. Schroder J., Tiilikainen A., and De la Chapelle A. Fetal leukocytes in the maternal circulation after delivery. I. Cytological aspects. Transplantation 17 (1974) 346-354
13. Bianchi D.W. Prenatal diagnosis by analysis of fetal cells in maternal blood. J Pediatr 127 (1995) 847-856
14. Lo Y.M., Lo E.S., Watson N., et al. Two-way cell traffic between mother and fetus. biologic and clinical implications. Blood 88 (1996) 4390-4395
15. Lo Y.M., Lau T.K., Chan L.Y., Leung T.N., and Chang A.M. Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem 46 (2000) 1301-1309
16. Thomas M.R., Williamson R., Craft I., Yazdani N., and Rodeck C.H. Y chromosome sequence DNA amplified from peripheral blood of women in early pregnancy. Lancet 343 (1994) 413-414
17. Stott L.M., Barker R.N., and Urbaniak S.J. Identification of alloreactive T-cell epitopes on the Rhesus D protein. Blood 96 (2000) 4011-4019
18. Newman P.J., McFarland J.G., and Aster R.H. Alloimmune thrombocytopenias. In: Loscalzo J., and Schafer A.I. (Eds). Thrombosis and Hemorrhage. 2nd ed. (1998), Williams & Wilkins, Baltimore 599-615
19. Skacel P.O., Stacey T.E., Tidmarsh C.E., and Contreras M. Maternal alloimmunization to HLA, platelet and granulocyte-specific antigens during pregnancy. its influence on cord blood granulocyte and platelet counts. Br J Haematol 71 (1989) 119-123
20. Regan L., Braude P.R., and Hill D.P. A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 6 (1991) 294-298
21. Rebibou J.M., Chabod J., Dupont I., Chalopin J.M., and Tiberghien P. The interest of flow cytometry for the detection of pregnancy-induced alloimmunization. Transplant Proc 32 (2000) 2747
22. Verdijk R.M., Kloosterman A., Pool J., et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells. implications for stem cell transplantation and immunotherapy. Blood 103 (2004) 1961-1964
23. Farber C.M., Wachtel S.S., and Cunningham-Rundles C. Immune complexes containing H-Y antigen and maternal IgG in cord serum. Clin Exp Immunol 50 (1982) 450-453
24. James E., Chai J.G., Dewchand H., Macchiarulo E., Dazzi F., and Simpson E. Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans. Blood 102 (2003) 388-393
25. Miklos D.B., Kim H.T., Zorn E., et al. Antibody responses to multiple H-Y minor histocompatibility antigens are induced after allogeneic stem cell transplantation and in normal female donors. Blood 102 (2003) 950a
26. Miklos D.B., Kim H.T., Zorn E., et al. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood 103 (2004) 353-359
27. Butturini A., Seeger R.C., and Gale R.P. Recipient immune-competent T lymphocytes can survive intensive conditioning for bone marrow transplantation. Blood 68 (1986) 954-956
28. Voogt P.J., Fibbe W.E., Marijt W.A., et al. Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet 335 (1990) 131-134
29. Gale R.P., Horowitz M.M., Butturini A., Barrett A.J., and Kolb H.J. What determines who develops graft-versus-host disease. the graft or the host (or both)?. Bone Marrow Transplant 10 (1992) 99-102
30. Bacigalupo A., Van Lint M.T., Occhini D., et al. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 45 (1988) 1091-1094
31. Stussi G., Seebach L., Muntwyler J., Schanz U., Gmur J., and Seebach J.D. Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation. a single-centre experience. Br J Haematol 113 (2001) 251-253
32. Worel N., Kalhs P., Keil F., et al. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion 43 (2003) 1153-1161
33. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18 (1974) 295-304
34. Gooley T.A., Leisenring W., Crowley J., and Storer B.E. Estimation of failure probabilities in the presence of competing risks. new representations of old estimators. Stat Med 18 (1999) 695-706
35. Klein J.P., Rizzo J.D., Zhang M.J., and Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: regression modeling. Bone Marrow Transplant 28 (2001) 1001-1011
36. Benjamini Y., and Hochberg Y. Controlling the false discovery rate. a practical and powerful approach to multiple testing. J R Stat Soc B 57 (1995) 289-300
37. Goulmy E., Termijtelen A., Bradley B.A., and van Rood J.J. Y-antigen killing by T cells of women is restricted by HLA. Nature 266 (1977) 544-545
38. Wang W., Meadows L.R., den Haan J.M., et al. Human H-Y. a male-specific histocompatibility antigen derived from the SMCY protein. Science 269 (1995) 1588-1590
39. Rufer N., Wolpert E., Helg C., et al. HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation. Transplantation 66 (1998) 910-916
40. Bianchi D.W., Zickwolf G.K., Weil G.J., Sylvester S., and DeMaria M.A. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 93 (1996) 705-708
41. Starzl T.E., Demetris A.J., Murase N., Trucco M., Thomson A.W., and Rao A.S. The lost chord. microchimerism and allograft survival. Immunol Today 17 (1996) 577-584
42. Evans P.C., Lambert N., Maloney S., Furst D.E., Moore J.M., and Nelson J.L. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 93 (1999) 2033-2037
43. Ichinohe T., Teshima T., Matsuoka K.-i., Maruya E., and Saji H. Fetal-maternal microchimerism. impact on hematopoietic stem cell transplantation. Curr Opin Immunol (2005) 17-546
44. Ochiai N., Shimazaki C., Fuchida S., et al. Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia. Bone Marrow Transplant 30 (2002) 793-796
45. Shimazaki C., Ochiai N., Uchida R., et al. Non-T-cell-depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal microchimerism. Blood 101 (2003) 3334-3336
46. Yoshihara T., Morimoto A., Inukai T., et al. Non-T-cell-depleted HLA haploidentical stem cell transplantation based on feto-maternal microchimerism in pediatric patients with advanced malignancies. Bone Marrow Transplant 34 (2004) 373-375
47. Hall J.M., Lingenfelter P., Adams S.L., Lasser D., Hansen J.A., and Bean M.A. Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization. Blood 86 (1995) 2829-2832
48. Maloney S., Smith A., Furst D.E., et al. Microchimerism of maternal origin persists into adult life. J Clin Invest 104 (1999) 41-47
49. Scaradavou A., Carrier C., Mollen N., Stevens C., and Rubinstein P. Detection of maternal DNA in placental/umbilical cord blood by locus-specific amplification of the noninherited maternal HLA gene. Blood 88 (1996) 1494-1500
50. Socie G., Gluckman E., Carosella E., Brossard Y., Lafon C., and Brison O. Search for maternal cells in human umbilical cord blood by polymerase chain reaction amplification of two minisatellite sequences. Blood 83 (1994) 340-344
51. Molitor M.L., Haynes L.D., Jankowska-Gan E., Mulder A., and Burlingham W.J. HLA class I noninherited maternal antigens in cord blood and breast milk. Hum Immunol 65 (2004) 231
52. van Rood J.J., Loberiza Jr. F.R., Zhang M.-J., et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood 99 (2002) 1572-1577
53. Ichinohe T., Uchiyama T., Shimazaki C., et al. Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism. Blood 104 (2004) 3821-3828
54. Lambert N.C., Evans P.C., Hashizumi T.L., et al. Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. J Immunol 164 (2000) 5545-5548
55. Johnson K.L., Samura O., Nelson J.L., McDonnell Md.W.M., and Bianchi D.W. Significant fetal cell microchimerism in a nontransfused woman with hepatitis C. Evidence of long-term survival and expansion. Hepatology 36 (2002) 1295-1297
56. Srivatsa B., Srivatsa S., Johnson K.L., Samura O., Lee S.L., and Bianchi D.W. Microchimerism of presumed fetal origin in thyroid specimens from women. a case-control study. Lancet 358 (2001) 2034-2038
57. Khosrotehrani K., and Bianchi D.W. Multi-lineage potential of fetal cells in maternal tissue. a legacy in reverse. J Cell Sci 118 (2005) 1559-1563
58. Nelson J.L., Furst D.E., Maloney S., et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 351 (1998) 559-562
59. Artlett C.M., Smith J.B., and Jimenez S.A. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 338 (1998) 1186-1191
60. Khosrotehrani K., Johnson K.L., Cha D.H., Salomon R.N., and Bianchi D.W. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA 292 (2004) 75-80
61. Adams K.M., Lambert N.C., Heimfeld S., et al. Male DNA in female donor apheresis and CD34-enriched products. Blood 102 (2003) 3845-3847